Esra Pehlivan
Istanbul, Üsküdar, 34668, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07061522
This observational case-control study will investigate the impact of smoking addiction on lower extremity speed and coordination in young adults. Participants aged 18-25 will be divided into two groups based on their smoking status. The study will compare motor coordination and sprint performance between smokers and non-smokers using objective physical tests under standardized laboratory conditions.
Interested in participating?
Request Info18 year–25 year
All sexes
Observational
Istanbul, Üsküdar, 34668, Turkey (Türkiye)
Location status: Recruiting
This non-randomized controlled study will aim to evaluate the effects of smoking addiction on the speed and coordination of lower extremity movements among healthy young adults. Smoking is known to have detrimental effects on vascular, musculoskeletal, and neurological systems, yet its impact on motor performance-particularly in the lower limbs-has not been sufficiently studied.
Participants aged 18-25 will be categorized into smoker and non-smoker groups based on DSM-IV-TR nicotine dependence criteria and the Fagerström Test. The Lower Extremity Motor Coordination Test (LEMOCOT) will be used to assess motor coordination, while a 30-meter sprint test will evaluate movement speed. Additionally, body mass index (BMI) and bimalleolar diameter and circumference will be recorded to control for confounding physical variables.
All assessments will be conducted in a controlled laboratory environment. The results will be analyzed to determine whether smoking addiction is associated with impaired lower limb motor function. The findings may provide new insights into the functional consequences of smoking in young adults and contribute to the design of preventive and rehabilitative strategies.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lower extremity coordination will be evaluated using the Lower Extremity Motor Coordination Test (LEMOCOT), and movement speed will be assessed with a 30-meter sprint test. All assessments will be conducted once in a controlled laboratory setting and are intended solely for comparative analysis between smokers and non-smokers.
Time frame: Baseline
Tool: LEMOCOT (Lower Extremity Motor Coordination Test) Description: Total number of valid taps within 20 seconds.
Time frame: Baseline
Tool: 30-Meter Sprint Test Description: Time in seconds taken to complete a 30-meter run at maximum speed.
Time frame: Baseline
Tool: Fagerström Test for Nicotine Dependence Description: Total score assessing severity of nicotine addiction.
Time frame: Baseline
Calculated as weight (kg)/height² (m²), to assess weight-related influence on movement.
Time frame: Baseline
Measured with caliper and tape to assess potential structural differences affecting motor coordination.
Contact information is provided by the study sponsor or research team.
Edanur Kocakaplan
CONTACT
Esra Pehlivan, Associate Professor
CONTACT
Saglik Bilimleri Universitesi
Other
Investigation of the Impact of Smoking Addiction on the Speed and Coordination of Lower Extremity Movements
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585357
Behavior, Health Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT06584929
Behavior, Health Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT07166120
Behavior, Health Behavior
St Louis, Missouri, United States
View Trial DetailsNCT06651684
Behavior, Chemically-Induced Disorders
Montreal, Quebec, Canada
View Trial Details